Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

T-Bank launched a loyalty program for shareholders

1/16/25 T

Fesco increased car transportation from China to Russia by 36%

1/16/25 FESH

Novatek's gas sales volume in 2024 decreased by 1.1%

1/16/25 NVTK

MD Medical opened a new clinic in Krasnogorsk

1/16/25 MDMG

Novabev Group shipments decreased by 4.2% in 2024

1/16/25 BELU

Henderson's revenue for 2024 grew 24.2 percent

1/16/25 HNFG

Softline obtained control in K2-9b Group

1/16/25 SOFL

M.Video-Eldorado to open 100 new stores in 2024

1/16/25 MVID

Nornickel to invest ₽25 billion in the Severny mine stripping project

1/15/25 GMKN

Number of private investors on Moscow Exchange exceeded 35 million

1/15/25 MOEX